scholarly journals Cholecystectomy Patients with High Plasma Level of Catalase Have Significantly Lower Analgesia Requirement: A Prospective Study of Two Different Cholecystectomy Techniques with Special Reference to Patients with Cancer

2018 ◽  
Vol 38 (9) ◽  
pp. 5417-5422
Author(s):  
IINA SAIMANEN ◽  
VIIVI KUOSMANEN ◽  
JARI KÄRKKÄINEN ◽  
TUOMAS SELANDER ◽  
SAMULI ASPINEN ◽  
...  
Keyword(s):  
Plasma Level ◽  
Prospective Study ◽  
Special Reference ◽  
High Plasma ◽  
Patients With Cancer ◽  
High Plasma Level ◽  
Analgesia Requirement ◽  
A Prospective Study

High Plasma Level ofN-Acetyl-Seryl-Aspartyl-Lysyl-Proline

Hypertension ◽  
1997 ◽  
Vol 30 (5) ◽  
pp. 1015-1019 ◽  
Author(s):  
Michel Azizi ◽  
Eric Ezan ◽  
Laurence Nicolet ◽  
Jean-Marc Grognet ◽  
Joël Ménard
Keyword(s):  
Plasma Level ◽  
High Plasma ◽  
High Plasma Level

High plasma level of long Pentraxin 3 is associated with insulin resistance in women with polycystic ovary syndrome

2012 ◽  
Vol 28 (9) ◽  
pp. 722-725 ◽  
Author(s):  
Aydogan Aydogdu ◽  
Ilker Tasci ◽  
Serkan Tapan ◽  
Yalcin Basaran ◽  
Umit Aydogan ◽  
...  
Keyword(s):  
Insulin Resistance ◽  
Plasma Level ◽  
Polycystic Ovary Syndrome ◽  
Polycystic Ovary ◽  
High Plasma ◽  
Pentraxin 3 ◽  
Ovary Syndrome ◽  
High Plasma Level

scholarly journals Quality of life and functional status in patients with cancer of the oral cavity and oropharynx: pretreatment values of a prospective study

2007 ◽  
Vol 264 (6) ◽  
pp. 651-657 ◽  
Author(s):  
Pepijn A. Borggreven ◽  
Irma M. Verdonck-de Leeuw ◽  
Martin J. Muller ◽  
Milou L. C. H. Heiligers ◽  
Remco de Bree ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Oral Cavity ◽  
Prospective Study ◽  
Functional Status ◽  
Patients With Cancer ◽  
A Prospective Study

scholarly journals Potential Drug-Drug and Herb-Drug Interactions in Patients With Cancer: A Prospective Study of Medication Surveillance

2017 ◽  
Vol 13 (7) ◽  
pp. e613-e622 ◽  
Author(s):  
Allan Ramos-Esquivel ◽  
Álvaro Víquez-Jaikel ◽  
Cristina Fernández
Keyword(s):  
High Risk ◽  
Prospective Study ◽  
Drug Interactions ◽  
Anticancer Therapy ◽  
Herbal Supplement ◽  
Herbal Supplements ◽  
Patients With Cancer ◽  
Clinical Consequences ◽  
Clinically Significant ◽  
A Prospective Study

Purpose: Patients with cancer frequently use herbal supplements and concomitant medications along with antineoplastic agents. These patients are at high risk of herb-drug interactions (HDIs) and drug-drug interactions (DDIs). We aimed to determine clinically relevant DDIs and HDIs leading to pharmaceutical intervention. Methods: Patients starting a new anticancer therapy were asked to complete a questionnaire to identify concomitant use of any over-the-counter drug or herbal supplement. Potential DDIs and HDIs were identified using two different databases. If a potentially clinically relevant DDI was recognized by the clinical pharmacist, a notification was sent to the prescribing oncologist, who decided whether to carry out a suggested intervention. Regression analyses were performed to identify variables associated with clinically relevant DDIs. Results: A total of 149 patients were included in this study, with 36 potentially clinically relevant DDIs identified in 26 patients (17.4%; 95% CI, 11.3% to 23.5%), all of them leading to therapy modifications. In total, four patients (2.7%; 95% CI, 0.1% to 5.3%) had experienced clinical consequences from DDIs at the time of pharmacist notification. Additionally, 84 patients (56.4%; 95% CI, 48.4% to 64.4%) reported using concurrent herbal supplements, and 122 possible HDIs were detected. Concomitant use of two or more drugs was independently associated with high risk of a clinically significant DDI (odds ratio, 2.53; 95% CI, 1.08 to 5.91; P = .03). Conclusion: Potentially clinically relevant DDIs and possible HDIs were frequently detected in this prospective study. A multidisciplinary approach is required to identify and avoid potentially harmful combinations with anticancer therapy.

EEG Appearances in Acute Carbamazepine Toxicity

1990 ◽  
Vol 9 (5) ◽  
pp. 313-315 ◽  
Author(s):  
R.S. Howard ◽  
P. StJ. Trend ◽  
H.R.A. Townsend
Keyword(s):  
Plasma Level ◽  
Acute Phase ◽  
Activated Charcoal ◽  
High Plasma ◽  
High Plasma Level ◽  
Delta Activity

A 16-year-old woman deliberately took a large, toxic overdose of carbamazepine and recovered despite a high plasma level. During the acute phase the EEG was dominated by occipital delta activity suggestive of a brainstem disorder. Following 24-h treatment with activated charcoal the plasma carbamazepine was cleared and the EEG returned to normal.

Sign in / Sign up

Export Citation Format

Share Document